Search results: Sage Journals

Free accessReview articleFirst published July, 2018

BAY 81-8973,a full-length recombinant factor VIII for the treatment of hemophilia A: product review

Johnny N. Mahlangu, Sanjay P. Ahuja, Jerzy Windyga [...]

Therapeutic Advances in Hematology

Open accessResearch articleFirst published 2024

Rescue immune tolerance induction with a recombinant factor Fc-fused VIII: prospective ReITIrate study of clinical,humoral and cellular immune responses

Christoph Königs, Shannon L. Meeks, Beatrice Nolan [...]

Therapeutic Advances in Hematology

Restricted accessCase reportFirst published August, 2020

Acquired Hemophilia A: A Case Report

Mark Shen, Shan Wang, Julia Sessa [...]

Journal of Pharmacy Practice

Restricted accessResearch articleFirst published August, 2014

Efficient Production of Dual Recombinant Adeno-Associated Viral Vectors for Factor VIII Delivery

Qizhao Wang, Biao Dong, Jenni Firrman [...]

Human Gene Therapy Methods (Part B)

Restricted accessResearch articleFirst published December, 1987

Stable Expression of Recombinant Factor VIII Molecules Using a Bovine Papillomavirus Vector

Nava Sarver, George A. Ricca, John Link [...]

DNA and Cell Biology

Restricted accessResearch articleFirst published May, 2002

Continuous Infusion of Coagulation Factor Products

Joan M Stachnik, Michael P Gabay

Annals of Pharmacotherapy

Restricted accessNewsFirst published August, 1994

Human Antibodies to Recombinant Factor VIII in Hemophiliacs

Jeanne M. Lusher

Journal of Interferon & Cytokine Research

Open accessResearch articleFirst published 2024

Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS

Wolfgang Miesbach, Nicola Curry, Paul Knöbl [...]

Therapeutic Advances in Hematology

Restricted accessResearch articleFirst published September, 1998

Haemophiliacs' Successful Claims for Recombinant Factor VIII Treatment?

Jenny L. Urwin

Journal of Patient Safety and Risk Management

Open accessResearch articleFirst published 2021

Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A

Yongqiang Zhao, Yu Hu, Jie Jin [...]

Clinical and Applied Thrombosis/Hemostasis

Free accessReview articleFirst published July, 2018

BAY 81-8973,a full-length recombinant factor VIII for the treatment of hemophilia A: product review

Johnny N. Mahlangu, Sanjay P. Ahuja, Jerzy Windyga [...]

Therapeutic Advances in Hematology

Open accessResearch articleFirst published 2024

Rescue immune tolerance induction with a recombinant factor Fc-fused VIII: prospective ReITIrate study of clinical,humoral and cellular immune responses

Christoph Königs, Shannon L. Meeks, Beatrice Nolan [...]

Therapeutic Advances in Hematology

Restricted accessCase reportFirst published August, 2020

Acquired Hemophilia A: A Case Report

Mark Shen, Shan Wang, Julia Sessa [...]

Journal of Pharmacy Practice

Restricted accessResearch articleFirst published August, 2014

Efficient Production of Dual Recombinant Adeno-Associated Viral Vectors for Factor VIII Delivery

Qizhao Wang, Biao Dong, Jenni Firrman [...]

Human Gene Therapy Methods (Part B)

Restricted accessResearch articleFirst published December, 1987

Stable Expression of Recombinant Factor VIII Molecules Using a Bovine Papillomavirus Vector

Nava Sarver, George A. Ricca, John Link [...]

DNA and Cell Biology

Restricted accessResearch articleFirst published May, 2002

Continuous Infusion of Coagulation Factor Products

Joan M Stachnik, Michael P Gabay

Annals of Pharmacotherapy

Restricted accessNewsFirst published August, 1994

Human Antibodies to Recombinant Factor VIII in Hemophiliacs

Jeanne M. Lusher

Journal of Interferon & Cytokine Research

Open accessResearch articleFirst published 2024

Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS

Wolfgang Miesbach, Nicola Curry, Paul Knöbl [...]

Therapeutic Advances in Hematology

Restricted accessResearch articleFirst published September, 1998

Haemophiliacs' Successful Claims for Recombinant Factor VIII Treatment?

Jenny L. Urwin

Journal of Patient Safety and Risk Management

Open accessResearch articleFirst published 2021

Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A

Yongqiang Zhao, Yu Hu, Jie Jin [...]

Clinical and Applied Thrombosis/Hemostasis